These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4641001)

  • 1. A photochemical affinity-labelling reagent for the opiate receptor(s).
    Winter BA; Goldstein A
    Mol Pharmacol; 1972 Nov; 8(6):601-11. PubMed ID: 4641001
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivity of narcotic glucuronides as analgesics and on guinea-pig ileum.
    Schulz R; Goldstein A
    J Pharmacol Exp Ther; 1972 Nov; 183(2):404-10. PubMed ID: 5083552
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of an opiate to protect mice against naloxone-precipitated withdrawal.
    Cheney DL; Judson BA; Goldstein A
    J Pharmacol Exp Ther; 1972 Aug; 182(2):189-94. PubMed ID: 5065486
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible alteration of opiate receptor function by a photoaffinity labelling reagent.
    Schulz R; Goldstein A
    Life Sci; 1975 Jun; 16(12):1843-8. PubMed ID: 1152614
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.
    Zhang A; Li F; Ding C; Yao Q; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2007 May; 50(11):2747-51. PubMed ID: 17488103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of the opiate receptor.
    Simon EJ
    Am J Med Sci; 1973 Sep; 266(3):160-8. PubMed ID: 4583407
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of p-chlorophenylalanine on opiate-induced running, analgesia, tolerance and physical dependence in mice.
    Cheney DL; Goldstein A
    J Pharmacol Exp Ther; 1971 Apr; 177(1):309-15. PubMed ID: 4254848
    [No Abstract]   [Full Text] [Related]  

  • 8. Stereospecific interaction of the quaternized opiate, N-methyllevorphanol, with opiate receptors.
    Opheim KE; Cox BM
    J Med Chem; 1976 Jun; 19(6):857-8. PubMed ID: 950661
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse.
    Rethy CR; Smith CB; Villarreal JE
    J Pharmacol Exp Ther; 1971 Feb; 176(2):472-9. PubMed ID: 5568788
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate receptor binding: effects of enzymatic treatments.
    Pasternak GW; Snyder SH
    Mol Pharmacol; 1974 Mar; 10(2):183-93. PubMed ID: 4212212
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular and metabolic tolerance to an opioid narcotic in mouse brain.
    Goldstein A; Judson BA; Sheehan P
    Br J Pharmacol; 1973 Jan; 47(1):138-40. PubMed ID: 4717014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific binding of narcotics to brain cerebrosides.
    Loh HH; Cho TM; Wu YC; Way EL
    Life Sci; 1974 Jun; 14(11):2231-45. PubMed ID: 4847814
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial purification of an opiate receptor from mouse brain.
    Lowney LI; Schulz K; Lowery PJ; Goldstein A
    Science; 1974 Feb; 183(4126):749-53. PubMed ID: 4821242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential pharmacokinetic and metabolic profiles of the stereoisomers of 3-hydroxy-N-methyl morphinan.
    Misra AL; Vadlamani NL; Bloch R; Mule SJ
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):1-16. PubMed ID: 4811450
    [No Abstract]   [Full Text] [Related]  

  • 17. Opiate binding to cerebroside sulfate: a model system for opiate-receptor interaction.
    Loh HH; Cho TM; Wu YC; Harris RA; Way EL
    Life Sci; 1975 Jun; 16(12):1811-7. PubMed ID: 1152609
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to opioid narcotics. I. Tolerance to the "running fit" caused by levorphanol in the mouse.
    Goldstein A; Sheehan P
    J Pharmacol Exp Ther; 1969 Oct; 169(2):175-84. PubMed ID: 5824602
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies.
    Kalpravidh M; Lumb WV; Wright M; Heath RB
    Am J Vet Res; 1984 Feb; 45(2):217-23. PubMed ID: 6711945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.